Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

 

 

 

FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Report of Foreign Private Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

 

For the month of January 2022

 

Commission File Number: 001-38562

 

NEW FRONTIER HEALTH CORPORATION
(Translation of Registrant’s Name into English)

 

10 Jiuxianqiao Road, 

Hengtong Business Park 

B7 Building, 1/F 

Chaoyang District, 100015 

Beijing, China
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes ¨ No ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes ¨ No ¨

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	New Frontier Health Corporation
	By:	/s/ Carl Wu
		Name:	Carl Wu
		Title:	Director

 

Date: January 26, 2022

 

Exhibit	Description of Exhibit
99.1	Press Release dated January 26, 2022 titled “New Frontier Health Corporation Announces Completion of Going Private Transaction”.